Crinetics Pharmaceuticals Reports Positive Interim Results for the ACROBAT Edge Phase 2 Trial of Paltusotine (CRN00808) in Acromegaly Patients and Provides Corporate UpdateGlobeNewsWire • 04/06/20
Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 03/04/20
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/12/19
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q3 Earnings Expected to DeclineZacks Investment Research • 11/05/19
Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare ConferenceGlobeNewsWire • 09/25/19
Crinetics Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 09/03/19